Tempus extends Recursion data deal to Nov 2029
Tempus AI extended its Recursion data partnership to Nov 2029, amended fees to $42M over three years (replacing potentially $84M over two years), and added a license for Recursion’s RNA sequencing model TxFM.
Tempus extended its Recursion data partnership to Nov 2029 and amended the fee terms, replacing potentially $84M over two years with $42M over three years. The company also licensed Recursion’s RNA sequencing model TxFM. The agreement extends a 2023 partnership and signals continued alignment between the two companies.